Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04841460 · ClinicalTrials.gov registry record · NA
Impact of Beef's Unique Food Matrix on Human Health
A NA study of Cholesterol, LDL and Research Subjects, sponsored by Texas A&M University.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
- 1
- Study location
NCT04841460: Completed NA study of Cholesterol, LDL and Research Subjects, sponsored by Texas A&M University.
NCT04841460 is a NA study of Cholesterol, LDL and Research Subjects that has completed, run by Texas A&M University. The registered enrollment target is 25 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04841460, a NA study of Cholesterol, LDL and Research Subjects, has completed, sponsored by Texas A&M University.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary goal of the proposed research is to document changes in plasma lipoprotein fractions, including high-density lipoprotein (HDL) and low-density lipoprotein (LDL) particle sizes and functionality, following the ground beef interventions. This specifically addresses the hypothesis that increasing the amount of fat in ground beef reduces risk factors for cardiovascular disease. Also, the investigators will measure changes in glucose, insulin, and triacylglycerols (TAG) following low-fat and high-fat ground beef interventions. An important aspect of this research is that the investigators will confirm that consumption of high-fat ground beef will reduce carbohydrate intake and increase insulin sensitivity in men. Furthermore, the investigators will be able to establish which protein sources are voluntarily replaced by the low- and high-fat ground beefs.
Primary Outcome
Lipoprotein cholesterol concentrations and density distributions
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Low-fat ground beef
- DIETARY_SUPPLEMENT High-fat ground beef
Study Locations (1)
Texas
- Texas A&M University - College Station
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2019-02-18 |
| Est. Completion | 2019-09-30 |
| Phase | NA |
What the finished NCT04841460 record still lists
NCT04841460 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 3 conditions, with Cholesterol, LDL appearing as the primary indexed condition, and to 2 interventions - of which Low-fat ground beef is the first listed.
NCT04841460 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT04841460 about?
NCT04841460 is a clinical study titled "Impact of Beef's Unique Food Matrix on Human Health". The primary goal of the proposed research is to document changes in plasma lipoprotein fractions, including high-density lipoprotein (HDL) and low-density lipoprotein (LDL) particle sizes and functionality, following the ground beef interventions. This specifically addresses the hypothesis that incr...
What is the current status of trial NCT04841460?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2019-02-18. Estimated completion is 2019-09-30.
What conditions does trial NCT04841460 study?
This clinical trial studies the following conditions: Cholesterol, LDL, Research Subjects, Cholesterol, HDL.
What interventions are being tested in trial NCT04841460?
The interventions under investigation include: Low-fat ground beef (DIETARY_SUPPLEMENT), High-fat ground beef (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04841460?
This trial is sponsored by Texas A&M University, which has 95 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04841460 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cholesterol, LDL
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04841460's enrollment target sits among peer trials
25 1712th of 2000 higher than 265 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI